Details of the Drug Combinations

General Information of This Drug (ID: DM4ZP3W)

Drug Name
Heparin   DM4ZP3W
Synonyms
enoxaparin; Ardeparin; Bemiparin; SEMULOPARIN; Lovenox; LMWH; Nadroparin; Nadroparine; Reviparin; Clivarin; Sublingula; Sandoparin; Parvoparin; Parnaparin; Novoheparin; Adomiparin; Tinzaparin; Multiparin; Hepathrom; Heparina; Triofiban; Pularin; Liquemin; Heparinum; Subeparin; PK-10169; Pabyrin; Octaparin; Liquaemin; Heparine; Vetren; Fluxum; Hed-heparin; Depo-Heparin; Lipo-hepin; Fragmin A; Fragmin B; Vitrum AB; Heparin [BAN]; Eparina [DCIT]; CY 216; Adomiparin [USAN]; FR 860; Heparin CY 216; Heparine [INN-French]
Indication
Disease Entry ICD 11 Status REF
Aplastic anemia 3A70 Approved [1]
Bacteremia 1A73 Approved [1]
Burns N.A. Approved [1]
Coronary heart disease BA80.Z Approved [1]
Deep vein thrombosis BD71 Approved [1]
Disseminated intravascular coagulation 3B20 Approved [1]
Metabolic disorder 5C50-5D2Z Approved [1]
Pneumonia CA40 Approved [1]
Pulmonary embolism BB00 Approved [1]
Venous thrombosis BA43 Approved [2]
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [3]
Diabetic angiopathy BD53.Y Investigative [1]
⏷ Show the Full List of Indication(s)
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

24 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Heparin + Bivalirudin DCCAQT0 Bivalirudin Coronary Microvascular Disease [4]
Heparin + Bivalirudin DC11GZG Bivalirudin Myocardial Infarction [5]
Heparin + Abciximab DC1HU8S Abciximab Angioplasty, Transluminal, Percutaneous Coronary [6]
Heparin + Aspirin DC517AV Aspirin Soft Tissue Neoplasms [7]
Heparin + Cloxacillin DC9JA26 Cloxacillin Double Lumen Infection [8]
Heparin + Tramadol DCDTSG1 Tramadol Second Degree Burns [9]
Heparin + Warfarin DCKIJUN Warfarin Mesenteric Vein Thrombosis [10]
Heparin + Heparin DCNBN4B Heparin COVID-19 [11]
Heparin + Minocycline DCPNBON Minocycline Acute Ischemic Stroke [12]
Heparin + Warfarin DCQXO7X Warfarin Deep Vein Thrombosis [13]
Heparin + Bivalirudin DCTIJK7 Bivalirudin Coronary Artery Disease [14]
Heparin + Triferic DCB0AAH Triferic End Stage Renal Disease [15]
Heparin + Ursodeoxycholic acid DCKWF9C Ursodeoxycholic acid Colorectal Cancer [16]
Heparin + Methylprednisolone DC1BSGA Methylprednisolone Covid19 [17]
Heparin + Methylprednisolone DCLYRM7 Methylprednisolone COVID-19 [18]
Heparin + Warfarin DCU1FOO Warfarin Atrial Fibrillation [19]
Heparin + Heparin DCKVQ54 Heparin COVID-19 [20]
Heparin + Heparin DC17N1X Heparin COVID-19 [21]
Heparin + Heparin DC6VD2X Heparin COVID-19 [20]
Heparin + Heparin DCHH2QQ Heparin STEMI - ST Elevation Myocardial Infarction [22]
Heparin + Papaverine DCJGS0N Papaverine Pediatrics [23]
Heparin + Aspirin DC1950E Aspirin Pregnancy [24]
Heparin + Papaverine DCGW68F Papaverine Pediatrics [23]
Heparin + Aspirin DCLV82T Aspirin Thrombophilia With Recurrent Pregnancy Loss [25]
------------------------------------------------------------------------------------
⏷ Show the Full List of 24 DrugCom(s)

References

1 Heparin FDA Label
2 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 090809.
3 Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020 Dec;9(1):727-732.
4 ClinicalTrials.gov (NCT03537586) A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
5 ClinicalTrials.gov (NCT00433966) Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
6 ClinicalTrials.gov (NCT00269880) A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.
7 ClinicalTrials.gov (NCT01965002) Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
8 ClinicalTrials.gov (NCT00885300) Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients
9 ClinicalTrials.gov (NCT02497326) Heparin for the Treatment of Burn Wound Pain
10 ClinicalTrials.gov (NCT03483207) Acute Mesenteric Venous Thrombosis.. in Assiut University Hospital Management Controversies
11 ClinicalTrials.gov (NCT05224388) Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
12 ClinicalTrials.gov (NCT00836355) Enoxaparin and/or Minocycline in Acute Stroke
13 ClinicalTrials.gov (NCT01780987) AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
14 ClinicalTrials.gov (NCT01464671) Angiomax or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
15 ClinicalTrials.gov (NCT04042324) A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
16 ClinicalTrials.gov (NCT01149304) Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
17 ClinicalTrials.gov (NCT04528888) Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
18 ClinicalTrials.gov (NCT04485429) Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia
19 ClinicalTrials.gov (NCT02072434) Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)
20 ClinicalTrials.gov (NCT04406389) Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)
21 ClinicalTrials.gov (NCT04409834) Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
22 ClinicalTrials.gov (NCT03664180) Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI
23 ClinicalTrials.gov (NCT03894904) Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients
24 ClinicalTrials.gov (NCT01917799) Aspirin, Heparin and Miscarriage
25 ClinicalTrials.gov (NCT02986594) Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla